EMAIL THIS PAGE TO A FRIEND

Analytica chimica acta

Dispersive micro-solid-phase extraction of benzodiazepines from biological fluids based on polyaniline/magnetic nanoparticles composite.


PMID 25172820

Abstract

In this study, diverse types of Fe3O4 nanocomposites modified by polyaniline, polypyrrole, and aniline-pyrrole copolymer were synthesized through chemical oxidative polymerization process for dispersive-μ-solid phase extraction (D-μ-SPE) in the presence of various dopants. The results showed that the nanocomposite modified by polyaniline with p-toluene sulfonic acid as a dopant demonstrated higher extraction efficiency for lorazepam (LRZ) and nitrazepam (NRZ). Also the synthesized magnetic sorbents were characterized. The nanocomposite sorbent in combination with high performance liquid chromatography-UV detection was applied for the extraction, preconcentration and determination of lorazepam and nitrazepam in urine and plasma samples. Different parameters influencing the extraction efficiency including: sample pH, amount of sorbent, sorption time, elution solvent and its volume, salt content, and elution time were optimized. The obtained optimal conditions were: sample pH, 6; amount of sorbent, 5 mg; sorption time, 5.0 min; elution solvent and its volume, 0.5 mM cethyltrimethyl ammonium bromide in acetonitrile, 150 μL; elution time, 2.0 min and without addition of NaCl. The calibration curves were linear in the concentration range of 1-2000 μg L(-1). The limits of detection (LODs) were achieved in the range of 0.5-1.8 μg L(-1) for NRZ and 0.2-2.0 μg L(-1) for LRZ, respectively. The percent of extraction recoveries and relative standard deviations (n=5) were in the range of 84.0-99.0, 6.1-7.8 for NRZ and 90.0-99.0, 4.1-7.0 for LRZ, respectively. Ultimately, the applicability of the method was successfully confirmed by the extraction and determination of NRZ and LRZ in human urine and plasma samples.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

279544
1-Propanol, anhydrous, 99.7%
C3H8O
96566
1-Propanol, analytical standard
C3H8O
09158
1-Propanol, for inorganic trace analysis, ≥99.8%
C3H8O
82092
1-Propanol, purum, ≥99.0% (GC)
C3H8O
W292818
1-Propanol, ≥99%, FG
C3H8O
W292826
1-Propanol, natural, ≥98%, FG
C3H8O
24-6080
1-Propanol, SAJ first grade, ≥99.0%
C3H8O
24-6070
1-Propanol, JIS special grade
C3H8O
1570406
1-Propanol, United States Pharmacopeia (USP) Reference Standard
C3H8O
PHR1208
1-Propanol, Pharmaceutical Secondary Standard; Certified Reference Material
C3H8O
380008
Ammonium bromide, 99.999% trace metals basis
H4BrN
467731
Ammonium bromide, ≥99.99% trace metals basis
H4BrN
213349
Ammonium bromide, ACS reagent, ≥99.0%
H4BrN
09715
Ammonium bromide, puriss. p.a., ACS reagent, ≥99.0% (AT)
H4BrN
451967
Ammonium bromide-79Br, 90 atom % 79Br
H479BrN
242284
Aniline, ACS reagent, ≥99.5%
C6H7N
132934
Aniline, ReagentPlus®, 99%
C6H7N
45326
Aniline, PESTANAL®, analytical standard
C6H7N
51788
Aniline, analytical standard
C6H7N
1102974
Cetrimonium bromide, United States Pharmacopeia (USP) Reference Standard
C19H42BrN
52369
Hexadecyltrimethylammonium bromide, BioUltra, ≥99.0% (AT)
C19H42BrN
52367
Hexadecyltrimethylammonium bromide, for ion pair chromatography
C19H42BrN
36932
Hexadecyltrimethylammonium bromide, analytical standard
C19H42BrN
52370
Hexadecyltrimethylammonium bromide, ≥96.0% (AT)
C19H42BrN
07883
Hexadecyltrimethylammonium bromide, puriss. p.a., matrix substance for MALDI-MS
C19H42BrN
451649
Iron(III) chloride, anhydrous, powder, ≥99.99% trace metals basis
Cl3Fe
701122
Iron(III) chloride, sublimed grade, ≥99.9% trace metals basis
Cl3Fe
361003
Iron(III) chloride on silica gel, powder, extent of labeling: 5 wt. % loading
Cl3Fe
710857
Iron(III) chloride solution, 0.2 M in 2-methyltetrahydrofuran
Cl3Fe
49817
Pyrrole, analytical standard
C4H5N